IDEAS home Printed from https://ideas.repec.org/a/abf/journl/v52y2023i4p44012-44022.html

Sipuleucel T- The Potential Arrival in the Field of Immunotherapy for Prostate Cancer

Author

Listed:
  • Teena Chhabra

    (ISF College Of Pharmacy, Moga, Punjab, India)

Abstract

Sipuleucel-T represents a novel immunotherapeutic compound designed to stimulate an immune response against metastatic castration-resistant prostate cancer (mCRPC). It is a personalized therapeutic vaccine in which individual patient-specific immune cells are used. It works by focusing on prostate cancer by triggering the patient’s own immune system. There are three doses total in a typical sipuleucel-T therapy regimen.

Suggested Citation

  • Teena Chhabra, 2023. "Sipuleucel T- The Potential Arrival in the Field of Immunotherapy for Prostate Cancer," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 52(4), pages 44012-44022, September.
    • Handle: RePEc:abf:journl:v:52:y:2023:i:4:p:44012-44022
    DOI: 10.26717/BJSTR.2023.52.008298
    as

    Download full text from publisher

    File URL: https://biomedres.us/pdfs/BJSTR.MS.ID.008298.pdf
    Download Restriction: no
    File URL: https://biomedres.us/fulltexts/BJSTR.MS.ID.008298.php
    Download Restriction: no
    File URL: https://libkey.io/10.26717/BJSTR.2023.52.008298?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Fengju Chen & Yiqun Zhang & Dominick Bossé & Aly-Khan A. Lalani & A. Ari Hakimi & James J. Hsieh & Toni K. Choueiri & Don L. Gibbons & Michael Ittmann & Chad J. Creighton, 2017. "Pan-urologic cancer genomic subtypes that transcend tissue of origin," Nature Communications, Nature, vol. 8(1), pages 1-15, December.
    2. Ugur Sahin & Evelyna Derhovanessian & Matthias Miller & Björn-Philipp Kloke & Petra Simon & Martin Löwer & Valesca Bukur & Arbel D. Tadmor & Ulrich Luxemburger & Barbara Schrörs & Tana Omokoko & Mathi, 2017. "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer," Nature, Nature, vol. 547(7662), pages 222-226, July.
    3. Christina Twyman-Saint Victor & Andrew J. Rech & Amit Maity & Ramesh Rengan & Kristen E. Pauken & Erietta Stelekati & Joseph L. Benci & Bihui Xu & Hannah Dada & Pamela M. Odorizzi & Ramin S. Herati & , 2015. "Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer," Nature, Nature, vol. 520(7547), pages 373-377, April.
    4. Patrick A. Ott & Zhuting Hu & Derin B. Keskin & Sachet A. Shukla & Jing Sun & David J. Bozym & Wandi Zhang & Adrienne Luoma & Anita Giobbie-Hurder & Lauren Peter & Christina Chen & Oriol Olive & Todd , 2017. "An immunogenic personal neoantigen vaccine for patients with melanoma," Nature, Nature, vol. 547(7662), pages 217-221, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Qing Li & Hao Zeng & Ting Liu & Peipei Wang & Rui Zhang & Binyan Zhao & Tang Feng & Yuling Yang & Jiumei Wu & Yue Zheng & Bailing Zhou & Yang Shu & Heng Xu & Li Yang & Zhenyu Ding, 2024. "A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
    2. Divya Lenkala & Jessica Kohler & Brian McCarthy & Michael Nelson & Noor A. M. Bakker & Renate de Boer & Emily K. Jackson & Joong Hyuk F. Sheen & Susan Hannes & Ekaterina Esaulova & Kai Stewart & Claud, 2026. "NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy," Nature Communications, Nature, vol. 17(1), pages 1-17, December.
    3. Naomi Hoenisch Gravel & Annika Nelde & Jens Bauer & Lena Mühlenbruch & Sarah M. Schroeder & Marian C. Neidert & Jonas Scheid & Steffen Lemke & Marissa L. Dubbelaar & Marcel Wacker & Anna Dengler & Rei, 2023. "TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    4. John P. Finnigan & Jenna H. Newman & Yury Patskovsky & Larysa Patskovska & Andrew S. Ishizuka & Geoffrey M. Lynn & Robert A. Seder & Michelle Krogsgaard & Nina Bhardwaj, 2024. "Structural basis for self-discrimination by neoantigen-specific TCRs," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    5. Jens Bauer & Natalie Köhler & Yacine Maringer & Philip Bucher & Tatjana Bilich & Melissa Zwick & Severin Dicks & Annika Nelde & Marissa Dubbelaar & Jonas Scheid & Marcel Wacker & Jonas S. Heitmann & S, 2022. "The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    6. Meghana Pagadala & Timothy J. Sears & Victoria H. Wu & Eva Pérez-Guijarro & Hyo Kim & Andrea Castro & James V. Talwar & Cristian Gonzalez-Colin & Steven Cao & Benjamin J. Schmiedel & Shervin Goudarzi , 2023. "Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    7. Franziska Füchsl & Johannes Untch & Vladyslav Kavaka & Gabriela Zuleger & Sarah Braun & Antonia Schwanzer & Sebastian Jarosch & Carolin Vogelsang & Niklas Andrade Krätzig & Dario Gosmann & Rupert Ölli, 2024. "High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    8. Hakimeh Ebrahimi-Nik & Marmar Moussa & Ryan P. Englander & Summit Singhaviranon & Justine Michaux & HuiSong Pak & Hiroko Miyadera & William L. Corwin & Grant L. J. Keller & Adam T. Hagymasi & Tatiana , 2021. "Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    9. Zhigang Liu & Dong Wang & Guanjun Li & Muhua Yi & Zhaoyuan Zhang & Guihua Zhong & Liangfu Xu & Rong Jiang & Yannan Zheng & Linxuan Huang & Yingpeng Peng & Lizhong Liang & Jianpeng Li & Ye Liu & Jun La, 2025. "Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial," Nature Communications, Nature, vol. 16(1), pages 1-14, December.
    10. Jun Jiang & Lili Yang & Qianqian Xie & Xi Liu & Jie Jiang & Jie Zhang & Shuping Zhang & Huizhen Zheng & Wenjie Li & Xiaoming Cai & Sijin Liu & Ruibin Li, 2024. "Synthetic vectors for activating the driving axis of ferroptosis," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    11. Ying Zhang & Raghava N. Sriramaneni & Paul A. Clark & Justin C. Jagodinsky & Mingzhou Ye & Wonjong Jin & Yuyuan Wang & Amber Bates & Caroline P. Kerr & Trang Le & Raad Allawi & Xiuxiu Wang & Ruosen Xi, 2022. "Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    12. Caroline P. Kerr & Won Jong Jin & Peng Liu & Joseph J. Grudzinski & Carolina A. Ferreira & Hansel Comas Rojas & Alejandro J. Oñate & Ohyun Kwon & Meredith Hyun & Malick Bio Idrissou & René Welch Schwa, 2026. "Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice," Nature Communications, Nature, vol. 17(1), pages 1-21, December.
    13. Qiuyue Wu & Wencheng Wang & Chi Zhang & Zhenlong You & Yinyan Zeng & Yinzhu Lu & Suhui Zhang & Xingrui Li & Chaoyong Yang & Yanling Song, 2023. "Capturing nascent extracellular vesicles by metabolic glycan labeling-assisted microfluidics," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    14. Sidsel Pedersen & Mikkel Byrdal & Evelina Martinenaite & Cathrine Lund Lorentzen & Julie Westerlin Kjeldsen & Steffen Ullitz Thorsen & Anders Kverneland & Mai-Britt Zocca & Mads Hald Andersen & Inge M, 2026. "Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma," Nature Communications, Nature, vol. 17(1), pages 1-7, December.
    15. Michael Launspach & Julia Macos & Shoaib Afzal & Janik Hohmann & Marc L. Appis & Maximilian Pilgram & Stefanie Beez & Emily Ohlendorf & Casper F. T. van der Ven & Chahrazad Lachiheb & Karin Töws & Len, 2025. "Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors," Nature Communications, Nature, vol. 16(1), pages 1-18, December.
    16. Jia He & Chaoyu Wang & Xiao Fang & Junyao Li & Xueying Shen & Junxia Zhang & Cheng Peng & Hongjian Li & Sai Li & Jeffrey M. Karp & Rui Kuai, 2024. "Tuning the fluidity and protein corona of ultrasound-responsive liposomal nanovaccines to program T cell immunity in mice," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    17. Nils-Petter Rudqvist & Maud Charpentier & Claire Lhuillier & Erik Wennerberg & Sheila Spada & Caroline Sheridan & Xi Kathy Zhou & Tuo Zhang & Silvia C. Formenti & Jennifer S. Sims & Alicia Alonso & Sa, 2023. "Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    18. Caroline S. Jansen & Meghana S. Pagadala & Maria A. Cardenas & Roshan S. Prabhu & Subir Goyal & Chengjing Zhou & Prasanthi Chappa & BaoHan T. Vo & Chengyu Ye & Benjamin Hopkins & Jim Zhong & Adam Klie, 2024. "Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    19. Jin Qu & Yuan Wang & Chuxiao Xiong & Mingxue Wang & Xingdao He & Weibin Jia & Cheuk Yin Li & Tianlong Zhang & Zixun Wang & Wei Li & Becki Yi Kuang & Peng Shi, 2024. "In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    20. Joseph Zenga & Musaddiq J. Awan & Anne Frei & Jamie Foeckler & Rachel Kuehn & Julia Kasprzak & Becky Massey & Jennifer Bruening & Kenneth Akakpo & Monica Shukla & Stuart J. Wong & Angela J. Mathison &, 2025. "Radiation therapy results in preferential tumor antigen-specific lymphodepletion in head and neck cancer," Nature Communications, Nature, vol. 16(1), pages 1-20, December.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;

    JEL classification:

    • R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
    • Z0 - Other Special Topics - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:abf:journl:v:52:y:2023:i:4:p:44012-44022. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Angela Roy (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.